Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
Soriano
E R
ER
Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires y Fundación Dr Pedro M. Catoggio para el Progreso de la Reumatología, Buenos Aires, Argentina.
Galarza-Maldonado
C
C
Cardiel
M H
MH
Pons-Estel
B A
BA
Massardo
L
L
Caballero-Uribe
C V
CV
Achurra-Castillo
A F
AF
Barile-Fabris
L A
LA
Chávez-Corrales
J
J
Díaz-Coto
J F
JF
Esteva-Spinetti
M H
MH
Guibert-Toledano
M
M
Palazuelos
F Irazoque
FI
Keiserman
M W
MW
Lomonte
A V
AV
Mota
L M H
LM
Pineda Villaseñor
C
C
Alarcón
G S
GS
D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000075202:Contraindications; D004334:Drug Administration Schedule; D006801:Humans; D007843:Latin America; D018579:Patient Selection; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab